Enbridge Rises as $1.2 Billion Share Sale Eases Funding Concerns
(Bloomberg) -- Enbridge Inc., North America's largest pipeline operator, posted its biggest stock surge in almost two years after a share sale and lowered dividend-growth forecast eased concerns about its ability to finance new projects.
The stock advanced as much as 8.3 percent to C$49.80 on Thursday in Toronto, the largest intraday gain since January 2016. Calgary-based Enbridge had slid 19 percent this year through Wednesday, compared with a 13 percent decline for the S&P/TSX energy index.
The gain comes a day after Enbridge announced plans to raise about C$1.5 billion ($1.2 billion) in a private share sale to pay down short-term debt and divest about C$10 billion in non-core assets. The company also tempered its forecast for dividend growth to a rate of 10 percent a year through 2020, down from earlier projections for a range of 10 percent to 12 percent.
The moves helped alleviate concerns about Enbridge's ability to maintain a strong balance sheet amid C$22 billion in spending on capital projects through 2020. While analysts said the dividend change was a slight negative, investors had been bracing for a steeper cut after the company declined to comment on its payout policy during its third-quarter earnings call.
“We view this as a prudent, yet difficult decision,” Ian Gillies, an analyst at GMP FirstEnergy, said in a note Thursday. “Investor focus can now return to Enbridge's significant capital program and execution of its business plan.”
Gillies upgraded his recommendation on the stock to buy from hold, and raised his target price to C$58 from C$54.
With its $28 billion acquisition of U.S. natural gas distributor Spectra Energy Corp. completed earlier this year, Enbridge now says it will concentrate on three core businesses of oil pipelines, gas pipelines and gas utilities. The sharper focus will result in Enbridge selling off at least C$3 billion in onshore renewables and unregulated gas midstream assets in 2018.
For its stock sale, three large institutional investors will buy about 33.5 million Enbridge shares for C$44.84 apiece, according to a statement Wednesday, representing a 3.5 percent discount to Tuesday's closing price. The company also said it plans to issue an additional C$4 billion of hybrid securities through the end of 2018.
--With assistance from Carlos Caminada
To contact the reporter on this story: Kevin Orland in Calgary at korland@bloomberg.net.
To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net, Joe Carroll
©2017 Bloomberg L.P.
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.